Evidence map›Paper›PMID 25174708›Full record

ArticleNature2014

High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.

Manon D Schulz, Ciğdem Atay, Jessica Heringer, Franziska K Romrig, Sarah Schwitalla, Begüm Aydin, Paul K Ziegler, Julia Varga, Wolfgang Reindl, Claudia Pommerenke and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 268 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 2 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 2 syntheses or guidelines pooled it, 450 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Purine salvage pathway protects CD8Nature immunology · 2026
    Article
  9. Article
  10. Article
  11. Diet-induced chromatin states influence intestinal stem cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  12. Rethinking the microenvironment's role in chemical-induced malignancy.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Article

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Manon D Schulz1] Institute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany [2].
Ciğdem Atay1] Institute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany [2].
Jessica Heringer1] Institute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany [2].
Franziska K RomrigInstitute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany.
Sarah SchwitallaInstitute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany.
Begüm AydinDepartment of Molecular Biology and Genetics, Bogazici University, 34342 Bebek, Istanbul, Turkey.
Paul K Ziegler1] Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt am Main, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany [3] German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Julia Varga1] Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt am Main, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany [3] German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Wolfgang ReindlDepartment of Internal Medicine II, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Claudia PommerenkeMicroarray and Deep-Sequencing Core Facility, University Medical Center Göttingen, 37077 Göttingen, Germany.
Gabriela Salinas-RiesterMicroarray and Deep-Sequencing Core Facility, University Medical Center Göttingen, 37077 Göttingen, Germany.
Andreas BöckInstitute for Mathematical Statistics, Technical University Munich, 81675 Munich, Germany.
Carl Alpert1] Department of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany [2].
Michael BlautDepartment of Gastrointestinal Microbiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany.
Sara C PolsonCenter for Bioinformatics and Computational Biology, Delaware Biotechnology Institute, University of Delaware, Newark, Delaware 19711, USA.
Lydia BrandlInstitute of Pathology, Ludwig Maximilians University, 80337 Munich, Germany.
Thomas Kirchner1] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany [2] German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [3] Institute of Pathology, Ludwig Maximilians University, 80337 Munich, Germany.
Florian R Greten1] Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt am Main, Germany [2] German Cancer Consortium (DKTK), 69120 Heidelberg, Germany [3] German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Shawn W PolsonCenter for Bioinformatics and Computational Biology, Delaware Biotechnology Institute, University of Delaware, Newark, Delaware 19711, USA.
Melek C ArkanInstitute of Molecular Immunology, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany.
Klinikum rechts der Isar · DEBiotechnology Institute · USGeorg Speyer Haus · DEGerman Institute of Human Nutrition · DEHeidelberg University · DEBoğaziçi University · TRGerman Cancer Research Center · DELudwig-Maximilians-Universität München · DEUniversitätsmedizin Göttingen · DEUniversity of Göttingen · DE

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
NIGMS NIH HHS 8 P20 GM103446-12NIGMS NIH HHS P20 GM103446
6 · The paper itself

Abstract

Several features common to a Western lifestyle, including obesity and low levels of physical activity, are known risk factors for gastrointestinal cancers. There is substantial evidence suggesting that diet markedly affects the composition of the intestinal microbiota. Moreover, there is now unequivocal evidence linking dysbiosis to cancer development. However, the mechanisms by which high-fat diet (HFD)-mediated changes in the microbial community affect the severity of tumorigenesis in the gut remain to be determined. Here we demonstrate that an HFD promotes tumour progression in the small intestine of genetically susceptible, K-ras(G12Dint), mice independently of obesity. HFD consumption, in conjunction with K-ras mutation, mediated a shift in the composition of the gut microbiota, and this shift was associated with a decrease in Paneth-cell-mediated antimicrobial host defence that compromised dendritic cell recruitment and MHC class II molecule presentation in the gut-associated lymphoid tissues. When butyrate was administered to HFD-fed K-ras(G12Dint) mice, dendritic cell recruitment in the gut-associated lymphoid tissues was normalized, and tumour progression was attenuated. Importantly, deficiency in MYD88, a signalling adaptor for pattern recognition receptors and Toll-like receptors, blocked tumour progression. The transfer of faecal samples from HFD-fed mice with intestinal tumours to healthy adult K-ras(G12Dint) mice was sufficient to transmit disease in the absence of an HFD. Furthermore, treatment with antibiotics completely blocked HFD-induced tumour progression, suggesting that distinct shifts in the microbiota have a pivotal role in aggravating disease. Collectively, these data underscore the importance of the reciprocal interaction between host and environmental factors in selecting a microbiota that favours carcinogenesis, and they suggest that tumorigenesis is transmissible among genetically predisposed individuals.

Indexed as

ObesityAnimalsAnti-Bacterial AgentsButyratesCarcinogenesisDietary FatsDiet, High-FatDisease ProgressionDysbiosisIntestinal MucosaIntestinal NeoplasmsIntestinesMicePrebioticsAnti-Bacterial AgentsButyratesDietary FatsPrebiotics

Identifiers

PMID25174708
PMCPMC4233209
OpenAlexW2074425838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.